Publications by authors named "Ingmar Lax"

Claim this Profile
V
Validated prediction of xerostomia in a real-world population: a step toward model-guided radiotherapy.
Emmy Dalqvist, Tiziana Rancati, Anna Embring, Gabriella Alexandersson von Döbeln, Ingmar Lax

Acta Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study.
Sara Lindberg, Vitali Grozman, Kristin Karlsson, Eva Onjukka, Elias Lindbäck, Ingmar Lax

Lung Cancer· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
Sara Lindberg, Vitali Grozman, Kristin Karlsson, Eva Onjukka, Elias Lindbäck, Ingmar Lax

Int J Radiat Oncol Biol Phys· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation in oropharyngeal cancer: a comparison of simultaneous integrated boost and brachytherapy boost.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund

Radiat Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiotherapy-Dose Escalated for Large Volume Primary Tumors-And Cetuximab with or without Induction Chemotherapy for HPV Associated Squamous Cell Carcinoma of the Head and Neck-A Randomized Phase II Trial.
Claes Mercke, Gun Wickart-Johansson, Helena Sjödin, Pedro Farrajota Neves da Silva, Gabriella Alexandersson von Döbeln, Ingmar Lax

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Escalation of Oropharyngeal Cancer: Long-Time Follow-Up and Side Effects.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund

Cancers (Basel)· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk for Hemorrhage the First 2 Years After Gamma Knife Surgery for Arteriovenous Malformations: An Update.
Bengt Karlsson, Hidefumi Jokura, Huai-Che Yang, Masaaki Yamamoto, Roberto Martinez-Alvarez, Ingmar Lax

Neurosurgery· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Response to Rosenberg et al. "The Nordic-HILUS Trial: Ultracentral Lung SABR and a Narrow Therapeutic Window".
Karin Lindberg, Ingmar Lax, Kristin Karlsson, Rolf Lewensohn

J Thorac Oncol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimation of delivered dose to lung tumours considering setup uncertainties and breathing motion in a cohort of patients treated with stereotactic body radiation therapy.
Kristin Karlsson, Ingmar Lax, Elias Lindbäck, Vitali Grozman, Karin Lindberg

Phys Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy.
Karin Lindberg, Vitali Grozman, Kristin Karlsson, Sara Lindberg, Ingmar Lax

J Thorac Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Re-Irradiation for Head and Neck Cancer: Cumulative Dose to Organs at Risk and Late Side Effects.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund

Cancers (Basel)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extending hypofractionated stereotactic body radiotherapy to tumours larger than 70cc - effects and side effects.
Vitali Grozman, Eva Onjukka, Peter Wersäll, Ingmar Lax, Georgios Tsakonas

Acta Oncol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling of Xerostomia After Radiotherapy for Head and Neck Cancer: A Registry Study.
Eva Onjukka, Claes Mercke, Einar Björgvinsson, Anna Embring, Anders Berglund, Ingmar Lax

Front Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overlapping volumes in re-irradiation for head and neck cancer - an important factor for patient selection.
Anna Embring, Eva Onjukka, Claes Mercke, Ingmar Lax, Anders Berglund

Radiat Oncol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
Karin Lindberg, Vitali Grozman, Sara Lindberg, Eva Onjukka, Ingmar Lax

Acta Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Acute Testicular Failure After Preoperative Radiotherapy for Rectal Cancer: A Prospective Cohort Study.
Christian Buchli, Anna Martling, Massoud Al Abani, Jan-Erik Frödin, Matteo Bottai, Ingmar Lax

Ann Surg· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy of the dose-shift approximation in estimating the delivered dose in SBRT of lung tumors considering setup errors and breathing motions.
Kristin Karlsson, Ingmar Lax, Elias Lindbäck, Gavin Poludniowski

Acta Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of testicular dose during preoperative radiotherapy for rectal cancer.
Christian Buchli, Massoud Al Abani, Madelene Ahlberg, Torbjörn Holm, Tone Fokstuen, Ingmar Lax

Acta Oncol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SPACE - A randomized study of SBRT vs conventional fractionated radiotherapy in medically inoperable stage I NSCLC.
Jan Nyman, Andreas Hallqvist, Jo-Åsmund Lund, Odd-Terje Brustugun, Bengt Bergman, Ingmar Lax

Radiother Oncol· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT - the Nordic experience.
Karin Lindberg, Jan Nyman, Vendela Riesenfeld Källskog, Morten Hoyer, Jo Å Lund, Ingmar Lax

Acta Oncol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Survival and tumour control probability in tumours with heterogeneous oxygenation: a comparison between the linear-quadratic and the universal survival curve models for high doses.
Emely Lindblom, Alexandru Dasu, Ingmar Lax, Iuliana Toma-Dasu

Acta Oncol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment fractionation for stereotactic radiotherapy of lung tumours: a modelling study of the influence of chronic and acute hypoxia on tumour control probability.
Emely Lindblom, Laura Antonovic, Alexandru Dasu, Ingmar Lax, Peter Wersäll

Radiat Oncol· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retrospective cohort study of bronchial doses and radiation-induced atelectasis after stereotactic body radiation therapy of lung tumors located close to the bronchial tree.
Kristin Karlsson, Jan Nyman, Pia Baumann, Peter Wersäll, Ninni Drugge, Ingmar Lax

Int J Radiat Oncol Biol Phys· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of fractionation in SBRT: analysis with the linear quadratic model and the universal survival curve model.
Berit Wennberg, Ingmar Lax

Acta Oncol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A retrospective study of SBRT of metastases in patients with primary sarcoma.
Christina Linder Stragliotto, Kristin Karlsson, Ingmar Lax, Eva Rutkowska, Jonas Bergh

Med Oncol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis